# Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled Formoterol

> **NCT00940329** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Roflumilast
- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT00940329
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2004-07
- **Final completion:** 2004-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940329, "Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled Formoterol". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00940329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*